Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2023-03-30 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于举行2022年度网上业绩说明会的通知
Investor Presentation Classification · 95% confidence The document is a notice about holding an online performance explanation meeting for the 2022 annual report. It mentions that the 2022 annual report has already been published on March 31, 2023, and the meeting is scheduled for April 7, 2023. The document invites investors to participate and submit questions for the meeting. The content is an announcement about an event related to the annual report, not the report itself. The document length is short (805 characters), and it serves as a notification rather than containing financial data or detailed report content. Therefore, it fits the category of an Investor Presentation (IP) or possibly an AGM Information (AGM-R). However, since it is specifically about an online performance explanation meeting (a form of investor presentation), the best fit is Investor Presentation (IP).
2023-03-30 Chinese
关于为子公司申请银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company providing guarantees for bank credit applications for its subsidiaries. It details the guarantee amounts, involved parties, financial data of the subsidiaries, and approvals from the board and independent directors. There is no indication that this is a financial report, audit report, or earnings release. It is a specific announcement about financing guarantees, which fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and contains substantive information about financing guarantees, not just a brief notice or report publication announcement. Therefore, the appropriate classification is CAP.
2023-03-30 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policies by the company 福安药业（集团）股份有限公司. It details the reasons for the change, the specific accounting standards affected, the approval process by the board and supervisory committee, and the impact of the change on financial statements. The document does not contain actual financial statements or comprehensive financial performance data but rather focuses on the policy change and related approvals. It is not a full annual or interim report, nor is it a certification or a brief announcement of a report publication. Given the content and length (under 5,000 characters), this fits best as a Regulatory Filing (RNS) because it is a formal regulatory announcement about accounting policy changes without substantive financial data or report content.
2023-03-30 Chinese
关于子公司参与全国药品集中采购拟中选的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its subsidiaries' participation and tentative selection in a national centralized drug procurement process. It details the products involved, their sales data, and the potential impact on the company. The document is relatively short (1960 characters) and does not contain financial statements or detailed financial analysis. It is an update on a specific business event rather than a full financial report or regulatory filing. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-03-30 Chinese
关于召开2022年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2022 Annual General Meeting (AGM) of 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It includes information about the meeting date, voting procedures, agenda items including approval of the 2022 annual report, audit report, profit distribution plan, and reappointment of auditors. The document is primarily an announcement to shareholders about the AGM logistics and agenda, not the actual annual report or audit report themselves. The document length is 4225 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2023-03-30 Chinese
关于使用闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the decision to use idle funds for cash management, including details about the investment plan, risk control, and approvals by the board and supervisory committee. It does not contain financial statements or detailed financial data but rather describes a corporate financing activity and the board's approval of it. The document length is short (2159 characters) and it is an announcement of a financing or capital management decision rather than a full financial report. Therefore, it fits best under Capital/Financing Update (CAP).
2023-03-30 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.